127 related articles for article (PubMed ID: 26457602)
1. Long-term Outcome of Kidney Recipients Transplanted for Aristolochic Acid Nephropathy.
Kanaan N; Hassoun Z; Raggi C; Jadoul M; Mourad M; De Meyer M; Aydin S; Schmeiser HH; Cosyns JP; Goffin E
Transplantation; 2016 Feb; 100(2):416-21. PubMed ID: 26457602
[TBL] [Abstract][Full Text] [Related]
2. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up.
Lemy A; Wissing KM; Rorive S; Zlotta A; Roumeguere T; Muniz Martinez MC; Decaestecker C; Salmon I; Abramowicz D; Vanherweghem JL; Nortier J
Am J Kidney Dis; 2008 Mar; 51(3):471-7. PubMed ID: 18295063
[TBL] [Abstract][Full Text] [Related]
3. De novo urothelial carcinoma in kidney transplant patients with end-stage aristolochic acid nephropathy in China.
Yuan M; Shi YB; Li ZH; Xia M; Ji GZ; Xu GX; Han Y
Transplant Proc; 2009 Jun; 41(5):1619-23. PubMed ID: 19545692
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy.
Shan H; Tian W; Hong Y; Xu B; Wang C; Yu B; Wang X
BMC Complement Med Ther; 2020 Jun; 20(1):166. PubMed ID: 32493345
[TBL] [Abstract][Full Text] [Related]
5. De novo urothelial carcinoma in kidney transplantation patients with end-stage aristolochic acid nephropathy in China.
Li HZ; Xia M; Han Y; Xu XG; Zhang YS
Urol Int; 2009; 83(2):200-5. PubMed ID: 19752617
[TBL] [Abstract][Full Text] [Related]
6. De Novo Bladder Urothelial Neoplasm in Renal Transplant Recipients: A Retrospective, Multicentered Study.
Palazzetti A; Bosio A; Dalmasso E; Destefanis P; Fop F; Pisano F; Segoloni G; Biancone L; Volpe A; Di Domenico A; Terrone C; Iesari S; Famulari A; Todeschini P; Frea B; Gontero P
Urol Int; 2018; 100(2):185-192. PubMed ID: 29342465
[TBL] [Abstract][Full Text] [Related]
7. Aristolochic acid nephropathy: variation in presentation and prognosis.
Yang L; Su T; Li XM; Wang X; Cai SQ; Meng LQ; Zou WZ; Wang HY
Nephrol Dial Transplant; 2012 Jan; 27(1):292-8. PubMed ID: 21719716
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch.
Riella LV; Safa K; Yagan J; Lee B; Azzi J; Najafian N; Abdi R; Milford E; Mah H; Gabardi S; Malek S; Tullius SG; Magee C; Chandraker A
Transplantation; 2014 Jun; 97(12):1247-52. PubMed ID: 24854670
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial.
Krämer BK; Klinger M; Vítko Š; Glyda M; Midtvedt K; Stefoni S; Citterio F; Pietruck F; Squifflet JP; Segoloni G; Krüger B; Sperschneider H; Banas B; Bäckman L; Weber M; Carmellini M; Perner F; Claesson K; Marcinkowski W; Ostrowski M; Senatorski G; Nordström J; Salmela K
Transplantation; 2012 Sep; 94(5):492-8. PubMed ID: 22858806
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing characteristics of urothelial carcinoma in kidney transplant recipients between China and Western countries.
Liu GM; Fang Q; Ma HS; Sun G; Wang XC
Transplant Proc; 2013; 45(6):2197-202. PubMed ID: 23747184
[TBL] [Abstract][Full Text] [Related]
11. Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.
Luciano RL; Perazella MA
Drug Saf; 2015 Jan; 38(1):55-64. PubMed ID: 25446374
[TBL] [Abstract][Full Text] [Related]
12. Association between urothelial carcinoma after kidney transplantation and aristolochic acid exposure: the potential role of aristolochic acid in HRas and TP53 gene mutations.
Xiao J; Zhu X; Hao GY; Zhu YC; Hou HJ; Zhang J; Ma LL; Tian Y; Zhang YH
Transplant Proc; 2011 Dec; 43(10):3751-4. PubMed ID: 22172840
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of renal patients from the Ivory Coast transplanted abroad: time for a local kidney transplantation program.
Ackoundou-N'Guessan C; Gnionsahe DA; Dekou AH; Tia WM; Guei CM; Moudachirou AM
Transplant Proc; 2010 Nov; 42(9):3517-20. PubMed ID: 21094807
[TBL] [Abstract][Full Text] [Related]
14. Five years renal transplantation data: Single-center experience from Iraq.
Ali AA; Al-Saedi AJ; Al-Mudhaffer AJ; Al-Taee KH
Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):341-7. PubMed ID: 26997389
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
[TBL] [Abstract][Full Text] [Related]
16. Effect of obesity on the outcome of kidney transplantation: a 20-year follow-up.
Hoogeveen EK; Aalten J; Rothman KJ; Roodnat JI; Mallat MJ; Borm G; Weimar W; Hoitsma AJ; de Fijter JW
Transplantation; 2011 Apr; 91(8):869-74. PubMed ID: 21326138
[TBL] [Abstract][Full Text] [Related]
17. What kind of changes occurred in clinical characteristics of deceased kidney donor recipients after national allocation system in Turkey? A single-center retrospective analysis.
Solak I; Sezer TO; Toz H; Tatar E; Sozbilen M; Firat O; Hoscoskun C
Transplant Proc; 2012; 44(6):1598-600. PubMed ID: 22841223
[TBL] [Abstract][Full Text] [Related]
18. Long-term maintenance immunosuppressive regimen with tacrolimus monotherapy.
Augusto JF; Subra JF; Onno C; Villemain F; Croue A; Dussaussoy C; Picquet J; Coeffic B; Sayegh J
Ann Transplant; 2013 Jul; 18():368-77. PubMed ID: 23872516
[TBL] [Abstract][Full Text] [Related]
19. Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function.
Gallon LG; Winoto J; Leventhal JR; Parker MA; Kaufman DB
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1029-38. PubMed ID: 17699323
[TBL] [Abstract][Full Text] [Related]
20. Early Predictors of Long-term Outcomes of HCV-negative Liver Transplant Recipients Having Survived the First Postoperative Year.
Åberg F; Nordin A; Toivonen L; Isoniemi H
Transplantation; 2016 Feb; 100(2):382-90. PubMed ID: 26683515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
